38952791 lipobay203body ap

The Baycol / Lipobay - Scandal

By Jan Solo
  • Drug approval in the UK

    Drug approval in the UK

  • Drug approval in Germany and other European countries

    Drug approval in Germany and other European countries

  • Drug approval in the USA

    Drug approval in the USA

  • First case of death linked to Lipobay

    The German Institute for Drugs and Medical Products (BfArM) receives the first case of death linked to Lipobay. The institute stated that there was the possibility that Lipobay caused a degeneration of muscles (rhabdomyolysis) which led to dead.

  • First case of death in the USA

  • Further cases of death are reported to the BfArM

  • Changing of patient information leaflet

    The britisch MCA and the german BfArM request Bayer to change the patient information leaflet according to EU law. They change is as requested and send out Direct Healthcare Professional Communication letters to doctors. However, a withdrawal of the product seems to be not necessary.
  • Withdrawal of Lipobay

    Withdrawal of Lipobay

    Bayer informs their shareholders about the withdrawal of Lipobay/Baycol. On the same day the US government agency FDA reports 31 cases of death which are linked to the usage of the product.
    Patients and doctors are anxious abecause of Bayer informing their shareholders a few hours before.

  • The German BfArM receives a report from Bayer about new hints about adverse effects

  • First charges in the USA against Bayer

  • Body of public prosecuters in Germany initiate investigation procedures against Bayer board members

  • Number of deaths reaches 100 cases

  • Bayer's operating profit down after heavy loses

  • Bayer Faces Over 2,000 Lawsuits In Wake Of Lipobay Scandal

    of which only a few finally end in successful compensations.

  • Items dropped by German Public prosecutors against Bayer due to not sufficient suspicion

  • Payment of financial compensation in Argentinia

    Bayer loses in court and has to pay 160.000€ to a person that took Lipobay and suffered irreversible lasting harm (Rhabdomyolyse, impaired vision, nephropathy).

  • Payment of financial compensation in Italy

    Bayer has to pay 350.000€ to a former doctor that has been invalid since taking Lipobay and after suffering a Rhabdomyolyse two months later. Bayer has to pay costs for the court as well.